Asterias (AST): Blazing the Stem Cell Trail for Spinal Cord Injury – Equities.com
Equities.com |
Asterias (AST): Blazing the Stem Cell Trail for Spinal Cord Injury
Equities.com Yesterday we highlighted the GTCbio Stem Cell Summit in Boston. Another company we've been closely following is also represented at the conference, Asterias Biotherapeutics (NYSE: AST). Asterias is developing therapies based on pluripotent stem cells … |
